A phase I study of oral dissolving strips for the delivery of Isoniazid in children and adults.

Trial Profile

A phase I study of oral dissolving strips for the delivery of Isoniazid in children and adults.

Planning
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Isoniazid (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Oct 2017 New trial record
    • 03 Oct 2017 According to an Oak Therapeutics media release, the Oak therapeutics received Small Business Innovative Research (SBIR) contract from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) for this Phase I project.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top